...
首页> 外文期刊>Physiological Research >Parathyroid Imaging by F-18-Fluorocholine PET/CT in Patients With Primary Hyperparathyroidism and Inconclusive Conventional Methods: Clinico-Pathological Correlations
【24h】

Parathyroid Imaging by F-18-Fluorocholine PET/CT in Patients With Primary Hyperparathyroidism and Inconclusive Conventional Methods: Clinico-Pathological Correlations

机译:F-18-荧光素PET / CT患者甲状旁腺成像在原发性甲状旁腺功能亢进症患者和常规方法:临床病理相关性

获取原文
获取原文并翻译 | 示例
           

摘要

F-18-fluorocholine positron emission tomography/computed tomography (FCH) was performed after inconclusive neck ultrasound and Tc-99-sestaMlBl SPECT (MIBI) scintigraphy in patients with primary hyperparathyroidism (PHPT) to localize abnormal parathyroid glands before surgery. The results were retrospectively evaluated and compared to postoperative histopathological findings. 13 patients with PHPT were enrolled (mean age 64.3 years, preoperative calcium 2.74 mmol/l and parathyroid hormone 114.6 ng/l). FCH localized hyperfunctioning parathyroid glands in 12 patients of 13 (per patient sensitivity 92 % and positive predictive value (PPV) 100 %). Fourteen parathyroid lesions (11 adenomas, 3 hyperplastic glands) were resected with a mean size of 11.9 mm (per lesion sensitivity 93 % and PPV 81 %). Four adenomas and one hyperplastic gland were composed of only chief cells, whereas five lesions contained both chief and oxyphil cells. In three patients an exclusively oxyphil adenoma was found, surprisingly with negative MIBI scintigraphy in spite of a high mitochondria content in the oxyphil parathyroid cells. 12 of 13 patients had thyroid disease. In our limited study sample, FCH correctly identified parathyroid adenomas and/or hyperplastic glands in 92 % of patients with previously inconclusive conventional imaging. Unlike MIBI, FCH successfully localized small, hyperplastic and multiple hyperfunctioning parathyroid glands, irrespective of their histopathological composition.
机译:F-18-氟胆碱正电子发射断层扫描/计算断层扫描(FCH)在颈部过敏性(PHPT)患者患者中的颈部超声和TC-99-Sestamlbl Spect(MIBI)闪烁术后进行,以在手术前定位异常的甲状旁腺。回顾性评估结果并与术后组织病理学发现进行了评估。 13名患有PHPT患者(平均64.3岁,术前钙2.74mmol / L和甲状旁腺激素114.6 ng / L)。 12名13例患者的甲状旁腺甲状旁腺(每个患者敏感性92%和阳性预测值(PPV)100%)。十四个甲状旁腺病变(11个腺瘤,3个增生腺),平均尺寸为11.9 mm(每个病变敏感性93%和PPV 81%)。四个腺瘤和一种增生腺体仅由主要细胞组成,而五个病变含有主要和烟碱。在三名患者中,发现了一个专门的杂种腺瘤,令人惊讶的是,由于烟草甲状旁腺细胞中的高线粒体含量,令人惊讶的是阴性mibi闪烁扫描。 13名患者中有12例患有甲状腺疾病。在我们有限的研究样本中,FCH在92%的患者中正确鉴定了先前不确定的传统成像的患者的甲状旁腺腺瘤和/或增生腺。与MIBI不同,FCH成功地局限性小型,过增殖和多功能的甲状旁腺,无论它们的组织病理组合物如何。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号